Campos, M.G.; China, M.; Cláudio, M.; Capinha, M.; Torres, R.; Oliveira, S.; Fortuna, A.
Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain. Pharmaceuticals 2024, 17, 613.
https://doi.org/10.3390/ph17050613
AMA Style
Campos MG, China M, Cláudio M, Capinha M, Torres R, Oliveira S, Fortuna A.
Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain. Pharmaceuticals. 2024; 17(5):613.
https://doi.org/10.3390/ph17050613
Chicago/Turabian Style
Campos, Maria G., Maria China, Mariana Cláudio, Miguel Capinha, Rita Torres, Simão Oliveira, and Ana Fortuna.
2024. "Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain" Pharmaceuticals 17, no. 5: 613.
https://doi.org/10.3390/ph17050613
APA Style
Campos, M. G., China, M., Cláudio, M., Capinha, M., Torres, R., Oliveira, S., & Fortuna, A.
(2024). Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain. Pharmaceuticals, 17(5), 613.
https://doi.org/10.3390/ph17050613
